Ann: Fluence First SUBRE Sale in Cambodia, page-3

I am not sure how the other competitors like Oxymem (Dupont) and Zeelung (Suez) are doing with their retrofit sales. But it is beginning to emerge that FLC is making inroads in emerging countries with SUBRE and Aspiral: Jamaica, China, Cambodia, Philippines etc., that is, these are 3rd world countries. The other two are making inroads in Europe, Canada, ie., first world countries.

Some market participants don't like emerging markets (vs mature markets) because of the political risks that comes with FLC biz etc. Others like it because that's where the growth is. For me, they have proven they can survive in China. That is a feat for a foreign company.

In any case, I like more spice in my food. I will go with FLC.